PRIA Logo™
119-s-5622119th Congress

Prosecuting Poison Pill Dealers Act

Sponsored By: Senator Moody, Ashley [R-FL]

Introduced

Summary

This bill would clarify when a controlled substance 'results' in death or serious bodily injury by defining 'substantial factor'. It adds two definitions to the Controlled Substances Act. "Results" would mean the use of a substance is a substantial factor in causing death or serious bodily injury. "Substantial factor" would mean the substance substantially contributes to the death or serious bodily injury even if other substances also contributed. The change would create a statutory causation standard that could underpin prosecutions tying a specific drug to a fatal or serious outcome.

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

Analyzed Economic Effects

1 provisions identified: 1 benefits, 0 costs, 0 mixed.

New rule for proving drug-caused deaths

If enacted, this bill would add two definitions to the Controlled Substances Act about when a substance's use 'results' in death or serious bodily injury. It would define 'results' to mean the substance's use is a substantial factor in causing the death or serious bodily injury. It would define 'substantial factor' to mean the use substantially contributes even if other substances also substantially contribute. This would affect how prosecutors and courts assess causation in drug-linked deaths, and this text does not create new programs, funding, or penalties by itself.

Sponsors & CoSponsors

Sponsor

Moody, Ashley [R-FL]

FL • R

Cosponsors

There are no cosponsors for this bill.

Roll Call Votes

No roll call votes available for this bill.

View on Congress.gov
Back to Legislation